Bayer and Loxo Oncology to develop and commercialize two therapies that selectively target genetic drivers of cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Bayer and Loxo Oncology to develop and commercialize two therapies that selectively target genetic drivers of cancer

Loxo Oncology (LOXO) to Resume Trading at 7:30 AM ET

November 14, 2017 7:20 AM EST

Loxo Oncology (NASDAQ: LOXO) to Resume Trading at 7:30 AM ET

... More